Lannett Company, Inc. (AMEX:LCI)

CAPS Rating: 3 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Recs

0
Player Avatar meberlein (< 20) Submitted: 8/3/2009 8:36:11 AM : Outperform Start Price: $8.64 LCI Score: -85.91

The stock has been on the rise as of late and is doing so on the back of solid financials. The company in the past five years has had a top out in the low twenties with similiar data to what it is displaying currently. 200% increase within the next 1-2 years.

Featured Broker Partners


Advertisement